Skip to content

A comparison between two bracing methods in idiopatic scoliosis: the Boston and a new developped brace.

A comparison between two bracing methods in idiopatic scoliosis: the Boston and a new developped brace.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24600
Enrollment
6
Registered
2009-01-20
Start date
2009-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brace, scolioses

Interventions

1. Customizing a new developed brace
2. Body brace interface pressure measurements
3. Conventional spinal x-rays.

Sponsors

Academic Hospital Maastricht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with idiopathic scoliosis, who are treated with a scoliosis brace; 2. Male and female patients; 3. Cobbs angle between 20o-40o at start of treatment; 4. Patients who read and understand the METC approved patient information; 5. Patients who are willing to participate and have written permission from their parents / guardians.

Exclusion criteria

Exclusion criteria: 1. Patients requiring surgical treatment (Cobbs angle >40o and progression); 2. Patients with other back problems; 3. Patients with spine operations in the past; 4. Patients with neurological signs; 5. Patients willing, but without parental / guardian permission; 6. Patients without a working knowledge of Dutch.

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of a new developed brace by means of comparing body brace interface pressure with measured Cobbs angles on the control X-rays.

Secondary

MeasureTime frame
Optimize the scoliosis brace treatment to the individual situation of each scoliosis patient by applying body brace interface pressure measurements in the regular care for patients with idiopathic scoliosis.

Contacts

Public ContactJ. Hermus
j.hermus@mumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)